EX-99.3 4 financialstatementsusgaapq.htm EX-99.3

Exhibit 99.3

ASML - Summary US GAAP Consolidated Statements of Operations

						Three months ended,												Twelve months ended,
						Dec 31,						Dec 31,						Dec 31,						Dec 31,
(unaudited, in millions €, except per share data)						2019						2020						2019						2020
Net system sales						3,130.7						3,198.3						8,996.2						10,316.6
Net service and field option sales						905.7						1,055.8						2,823.8						3,661.9
Total net sales						4,036.4						4,254.1						11,820.0						13,978.5
Total cost of sales						(2,096.3)						(2,043.0)						(6,540.2)						(7,181.3)
Gross profit						1,940.1						2,211.1						5,279.8						6,797.2
Research and development costs						(516.1)						(555.9)						(1,968.5)						(2,200.8)
Selling, general and administrative costs						(147.6)						(151.5)						(520.5)						(544.9)
Income from operations						1,276.5						1,503.7						2,790.8						4,051.5
Interest and other, net						(4.8)						(8.0)						(25.0)						(34.9)
Income before income taxes						1,271.7						1,495.7						2,765.8						4,016.6
Income tax expense						(124.5)						(170.2)						(191.7)						(551.5)
Income after income taxes						1,147.2						1,325.5						2,574.1						3,465.1
Profit (loss) related to equity method investments						(13.1)						25.0						18.2						88.6
Net income						1,134.1						1,350.5						2,592.3						3,553.7
Basic net income per ordinary share						2.70						3.23						6.16						8.49
Diluted net income per ordinary share						2.69						3.23						6.15						8.48
Weighted average number of ordinary shares used in computing per share amounts (in millions):
Basic						420.1						417.5						420.8						418.3
Diluted						421.1						418.4						421.6						419.1

ASML - Ratios and Other Data

						Three months ended,												Twelve months ended,
						Dec 31,						Dec 31,						Dec 31,						Dec 31,
(unaudited, in millions €, except otherwise indicated)						2019						2020						2019						2020
Gross profit as a percentage of net sales						48.1		%				52.0		%				44.7		%				48.6		%
Income from operations as a percentage of net sales						31.6		%				35.3		%				23.6		%				29.0		%
Net income as a percentage of net sales						28.1		%				31.7		%				21.9		%				25.4		%
Income taxes as a percentage of income before income taxes						9.8		%				11.4		%				6.9		%				13.7		%
Shareholders’ equity as a percentage of total assets						55.6		%				50.8		%				55.6		%				50.8		%
Sales of lithography systems (in units) 1						76						80						229						258
Value of booked systems (EUR millions) 2						2,402						4,238						11,740						11,292
Net bookings lithography systems (in units) 1, 2, 3						60						123						236						303
Number of payroll employees in FTEs						23,219						26,614						23,219						26,614
Number of temporary employees in FTEs						1,681						1,459						1,681						1,459

1     Lithography systems do not include metrology and inspection systems.

2 Our systems net bookings include all system sales orders for which written authorizations have been accepted (for EUV excluding the High-NA systems).

3 Our Q3 2019 systems net bookings include 1 DUV system shipped to collaborative Research Center (Imec) in Q3 2019. This system is not recognized in revenue.

---

ASML - Summary US GAAP Consolidated Balance Sheets

						Dec 31,						Dec 31,
(unaudited, in millions €)						2019						2020
ASSETS
Cash and cash equivalents						3,532.3						6,049.4
Short-term investments						1,185.8						1,302.2
Accounts receivable, net						1,786.8						1,310.3
Finance receivables, net						564.5						1,710.5
Current tax assets						178.7						67.3
Contract assets						231.0						119.2
Inventories, net						3,809.2						4,569.4
Other assets						842.8						801.7
Total current assets						12,131.1						15,930.0
Finance receivables, net						421.1						400.5
Deferred tax assets						445.3						671.5
Other assets						830.4						951.4
Equity method investments						833.0						820.7
Goodwill						4,541.1						4,629.1
Other intangible assets, net						1,104.4						1,049.0
Property, plant and equipment, net						1,999.3						2,470.3
Right-of-use assets - Operating						205.4						180.1
Right-of-use assets - Finance						118.5						164.8
Total non-current assets						10,498.5						11,337.4
Total assets						22,629.6						27,267.4
LIABILITIES AND SHAREHOLDERS’ EQUITY
Total current liabilities						4,694.1						6,603.5
Long-term debt						3,108.3						4,662.8
Deferred and other tax liabilities						234.4						238.3
Contract liabilities						1,759.6						1,639.9
Accrued and other liabilities						241.0						257.5
Total non-current liabilities						5,343.3						6,798.5
Total liabilities						10,037.4						13,402.0
Total shareholders’ equity						12,592.2						13,865.4
Total liabilities and shareholders’ equity						22,629.6						27,267.4

---

ASML - Summary US GAAP Consolidated Statements of Cash Flows

						Three months ended,												Twelve months ended,
						Dec 31,						Dec 31,						Dec 31,						Dec 31,
(unaudited, in millions €)						2019						2020						2019						2020
CASH FLOWS FROM OPERATING ACTIVITIES
Net income						1,134.1						1,350.6						2,592.3						3,553.7
Adjustments to reconcile net income to net cash flows from operating activities:
Depreciation and amortization						122.9						125.4						448.5						490.8
Impairment						—						—						4.7						2.7
Loss on disposal of property, plant and equipment						0.8						0.8						3.1						2.8
Share-based compensation expense						29.2						6.2						74.6						53.9
Allowance for obsolete inventory						54.2						77.6						221.5						192.4
Deferred income taxes						(80.9)						(60.7)						(200.0)						(211.3)
Equity method investments						107.8						95.8						56.9						11.0
Changes in assets and liabilities						2,220.2						3,074.7						74.8						531.6
Net cash provided by (used in) operating activities						3,588.3						4,670.4						3,276.4						4,627.6
CASH FLOWS FROM INVESTING ACTIVITIES
Purchase of property, plant and equipment						(305.5)						(292.9)						(766.6)						(962.0)
Purchase of intangible assets						(9.7)						(12.2)						(119.3)						(38.8)
Purchase of short-term investments						(902.4)						(820.8)						(1,291.5)						(1,475.5)
Maturity of short-term investments						200.3						394.8						1,019.0						1,359.1
Loans issued and other investing						0.9						(2.2)						0.9						(12.2)
Acquisition of subsidiaries (net of cash acquired)						—						(222.8)						—						(222.8)
Net cash provided by (used in) investing activities						(1,016.4)						(956.1)						(1,157.5)						(1,352.2)
CASH FLOWS FROM FINANCING ACTIVITIES
Dividend paid						(441.3)						(501.6)						(1,325.7)						(1,066.4)
Purchase of shares						(191.6)						(700.0)						(410.0)						(1,207.5)
Net proceeds from issuance of shares						7.2						7.9						27.2						37.9
Net proceeds from issuance of notes, net of issuance costs						—						—						—						1,486.3
Repayment of debt and finance lease obligations						(0.9)						(0.7)						(3.8)						(3.3)
Net cash provided by (used in) financing activities						(626.4)						(1,194.4)						(1,712.3)						(753.0)
Net cash flows						1,945.3						2,519.9						406.6						2,522.4
Effect of changes in exchange rates on cash						0.9						(2.0)						4.6						(5.3)
Net increase (decrease) in cash and cash equivalents						1,946.2						2,517.9						411.2						2,517.1
Cash and cash equivalents at beginning of the period						1,586.1						3,531.5						3,121.1						3,532.3
Cash and cash equivalents at end of the period						3,532.3						6,049.4						3,532.3						6,049.4

---

ASML - Quarterly Summary US GAAP Consolidated Statements of Operations

			Three months ended,
						Dec 31,						Mar 29,						Jun 28,						Sep 27,						Dec 31,
(unaudited, in millions €, except per share data)						2019						2020						2020						2020						2020
Net system sales						3,130.7						1,584.0						2,438.6						3,095.6						3,198.3
Net service and field option sales						905.7						856.6						887.1						862.4						1,055.8
Total net sales						4,036.4						2,440.6						3,325.7						3,958.0						4,254.1
Total cost of sales						(2,096.3)						(1,339.2)						(1,722.5)						(2,076.6)						(2,043.0)
Gross profit						1,940.1						1,101.4						1,603.2						1,881.4						2,211.1
Research and development costs						(516.1)						(544.0)						(566.9)						(534.0)						(555.9)
Selling, general and administrative costs						(147.6)						(130.7)						(131.2)						(131.5)						(151.5)
Income from operations						1,276.5						426.7						905.1						1,215.9						1,503.7
Interest and other, net						(4.8)						(11.4)						(7.1)						(8.4)						(8.0)
Income before income taxes						1,271.7						415.3						898.0						1,207.5						1,495.7
Benefit from (provision for) income taxes						(124.5)						(48.5)						(166.4)						(166.5)						(170.2)
Income after income taxes						1,147.2						366.8						731.6						1,041.0						1,325.5
Profit (loss) related to equity method investments						(13.1)						23.8						19.4						20.5						25.0
Net income						1,134.1						390.6						751.0						1,061.5						1,350.5
Basic net income per ordinary share						2.70						0.93						1.79						2.54						3.23
Diluted net income per ordinary share						2.69						0.93						1.79						2.53						3.23
Weighted average number of ordinary shares used in computing per share amounts (in millions):
Basic						420.1						419.0						418.4						418.4						417.5
Diluted						421.1						419.7						419.0						419.2						418.4

ASML - Quarterly Summary Ratios and other data

						Dec 31,						Mar 29,						Jun 28,						Sep 27,						Dec 31,
(unaudited, in millions €, except otherwise indicated)						2019						2020						2020						2020						2020
Gross profit as a percentage of net sales						48.1		%				45.1		%				48.2		%				47.5		%				52.0		%
Income from operations as a percentage of net sales						31.6		%				17.5		%				27.2		%				30.7		%				35.3		%
Net income as a percentage of net sales						28.1		%				16.0		%				22.6		%				26.8		%				31.7		%
Income taxes as a percentage of income before income taxes						9.8		%				11.7		%				18.5		%				13.8		%				11.4		%
Shareholders’ equity as a percentage of total assets						55.6		%				53.8		%				52.2		%				54.0		%				50.8		%
Sales of lithography systems (in units) 1						76						57						61						60						80
Value of booked systems (EUR millions) 2						2,402						3,085						1,101						2,868						4,238
Net bookings lithography systems (in units) 1, 2						60						73						34						73						123
Number of payroll employees in FTEs						23,219						23,860						24,330						24,749						26,614
Number of temporary employees in FTEs						1,681						1,467						1,482						1,451						1,459

1     Lithography systems do not include metrology and inspection systems.

2 Our systems net bookings include all system sales orders for which written authorizations have been accepted (for EUV excluding the High-NA systems).

---

ASML - Quarterly Summary US GAAP Consolidated Balance Sheets

						Dec 31,						Mar 29,						Jun 28,						Sep 27,						Dec 31,
(unaudited, in millions €)						2019						2020						2020						2020						2020
ASSETS
Cash and cash equivalents						3,532.3						2,723.7						3,499.1						3,531.5						6,049.4
Short-term investments						1,185.8						1,388.1						941.2						876.3						1,302.2
Accounts receivable, net						1,786.8						1,767.4						1,770.0						2,458.8						1,310.3
Finance receivables, net						564.5						748.7						1,071.5						1,855.4						1,710.5
Current tax assets						178.7						529.0						360.8						265.6						67.3
Contract assets						231.0						292.1						260.9						176.8						119.2
Inventories, net						3,809.2						4,345.3						4,685.6						4,613.7						4,569.4
Other assets						842.8						905.8						903.5						772.7						801.7
Total current assets						12,131.1						12,700.1						13,492.6						14,550.8						15,930.0
Finance receivables, net						421.1						340.8						444.0						349.6						400.5
Deferred tax assets						445.3						482.3						485.3						610.7						671.5
Other assets						830.4						902.3						929.7						961.5						951.4
Equity method investments						833.0						865.1						891.6						918.0						820.7
Goodwill						4,541.1						4,541.1						4,541.1						4,541.1						4,629.1
Other intangible assets, net						1,104.4						1,082.5						1,058.3						1,035.4						1,049.0
Property, plant and equipment, net						1,999.3						2,046.9						2,109.6						2,198.3						2,470.3
Right-of-use assets - Operating						205.4						197.1						193.0						180.1						180.1
Right-of-use assets - Finance						118.5						119.4						160.9						117.9						164.8
Total non-current assets						10,498.5						10,577.5						10,813.5						10,912.6						11,337.4
Total assets						22,629.6						23,277.6						24,306.1						25,463.4						27,267.4
LIABILITIES AND SHAREHOLDERS’ EQUITY
Total current liabilities						4,694.1						4,677.4						4,631.3						4,990.9						6,603.5
Long-term debt						3,108.3						3,868.2						4,625.0						4,626.7						4,662.8
Deferred and other tax liabilities						234.4						262.7						191.3						209.1						238.3
Contract liabilities						1,759.6						1,702.6						1,918.1						1,652.8						1,639.9
Accrued and other liabilities						241.0						241.5						240.6						241.4						257.5
Total non-current liabilities						5,343.3						6,075.0						6,975.0						6,730.0						6,798.5
Total liabilities						10,037.4						10,752.4						11,606.3						11,720.9						13,402.0
Total shareholders’ equity						12,592.2						12,525.2						12,699.8						13,742.5						13,865.4
Total liabilities and shareholders’ equity						22,629.6						23,277.6						24,306.1						25,463.4						27,267.4

---

ASML - Quarterly Summary US GAAP Consolidated Statements of Cash Flows

			Three months ended,
						Dec 31,						Mar 29,						Jun 28,						Sep 27,						Dec 31,
(unaudited, in millions €)						2019						2020						2020						2020						2020
CASH FLOWS FROM OPERATING ACTIVITIES
Net income						1,134.1						390.6						751.0						1,061.5						1,350.6
Adjustments to reconcile net income to net cash flows from operating activities:
Depreciation and amortization						122.9						118.3						125.1						122.0						125.4
Impairment						—						2.7						—						—						—
Loss on disposal of property, plant and equipment						0.8						1.0						0.2						0.8						0.8
Share-based compensation expense						29.2						14.9						10.3						22.5						6.2
Allowance for obsolete inventory						54.2						39.3						39.2						36.3						77.6
Deferred income taxes						(80.9)						(24.6)						(15.4)						(110.6)						(60.7)
Equity method investments						107.8						(32.3)						(26.4)						(26.1)						95.8
Changes in assets and liabilities						2,220.2						(1,115.7)						(512.1)						(915.3)						3,074.7
Net cash provided by (used in) operating activities						3,588.3						(605.8)						371.9						191.1						4,670.4
CASH FLOWS FROM INVESTING ACTIVITIES
Purchase of property, plant and equipment						(305.5)						(231.5)						(225.1)						(212.5)						(292.9)
Purchase of intangible assets						(9.7)						(10.8)						(6.7)						(9.1)						(12.2)
Purchase of short-term investments						(902.4)						(310.5)						(0.5)						(343.7)						(820.8)
Maturity of short-term investments						200.3						108.2						447.4						408.7						394.8
Loans issued and other investing						0.9						0.3						(0.3)						(10.0)						(2.2)
Acquisition of subsidiaries (net of cash acquired)						—						—						—						—						(222.8)
Net cash provided by (used in) investing activities						(1,016.4)						(444.3)						214.8						(166.6)						(956.1)
CASH FLOWS FROM FINANCING ACTIVITIES
Dividend paid						(441.3)						—						(564.8)						—						(501.6)
Purchase of shares						(191.6)						(507.5)						—						—						(700.0)
Net proceeds from issuance of shares						7.2						8.6						11.0						10.4						7.9
Net proceeds from issuance of notes, net of issuance costs						—						739.8						746.5						—						—
Repayment of debt and finance lease obligations						(0.9)						(0.9)						(0.8)						(0.9)						(0.7)
Net cash provided by (used in) financing activities						(626.4)						240.0						191.9						9.5						(1,194.4)
Net cash flows						1,945.3						(810.1)						778.6						34.0						2,519.9
Effect of changes in exchange rates on cash						0.9						1.5						(3.2)						(1.6)						(2.0)
Net increase (decrease) in cash and cash equivalents						1,946.2						(808.6)						775.4						32.4						2,517.9
Cash and cash equivalents at beginning of the period						1,586.1						3,532.3						2,723.7						3,499.1						3,531.5
Cash and cash equivalents at end of the period						3,532.3						2,723.7						3,499.1						3,531.5						6,049.4

---

Notes to the Summary US GAAP Consolidated Financial Statements

Basis of preparation

The accompanying unaudited Summary Consolidated Financial Statements have been prepared in conformity with the accounting principles generally accepted in the United States of America ("US GAAP").

For further details on our annual disclosure requirements under US GAAP, including our significant accounting policies, these interim unaudited Summary Consolidated Financial Statements should be read in conjunction with the Consolidated Financial Statements and Notes included within our 2019 Integrated Report based on US GAAP, which is available on www.asml.com.

---

Forward Looking Statements

This document contains statements that are forward-looking, including statements with respect to expected trends, including trends in end markets and technology industry and business environment trends, outlook and expected financial results for Q1 2021, including expected revenues, gross margin, R&D costs, SG&A costs and estimated annualized effective tax rate for 2021, expected growth in net sales in 2021, expected strong Logic demand and continued recovery in Memory, long term growth opportunity, revenue opportunity through 2025, expected benefits and performance of new systems and applications, the expectation that EUV will continue to enable Moore's law and drive long term value for ASML, statements with respect to plans regarding dividends, including the intention to continue to return significant amounts of cash to shareholders through a combination of share buybacks and growing dividends, the amount of the final dividend for 2020 and statements with respect to the 2020-2022 share buyback program including the amount of shares intended to be repurchased under the program. You can generally identify these statements by the use of words like "may", "will", "could", "should", "project", "believe", "anticipate", "expect", "plan", "estimate", "forecast", "potential", "intend", "continue", "target", and variations of these words or comparable words. These statements are not historical facts, but rather are based on current expectations, estimates, assumptions and projections about our business and our future financial results and readers should not place undue reliance on them. Forward-looking statements do not guarantee future performance and involve risks and uncertainties. These risks and uncertainties include, without limitation, economic conditions; product demand and semiconductor equipment industry capacity; worldwide demand and manufacturing capacity utilization for semiconductors; the impact of general economic conditions on consumer confidence and demand for our customers’ products; performance of our systems, the duration and continued or increased severity of the COVID-19 outbreak and measures taken to contain it and other risks related to the impact of COVID-19 on the global economy and financial markets, as well as on ASML and its customers and suppliers, including their operations, and other risks relating to COVID-19 and other factors that may impact ASML’s sales and gross margin, including customer demand and ASML’s ability to obtain supplies for its products, the success of technology advances and the pace of new product development and customer acceptance of and demand for new products; the number and timing of systems ordered, shipped and recognized in revenue, and the risk of order cancellation or push out, production capacity for our systems including delays in system production; our ability to enforce patents and protect intellectual property rights and the outcome of intellectual property disputes and litigation; availability of raw materials, critical manufacturing equipment and qualified employees; trade environment; import/export and national security regulations and orders and their impact on us, changes in exchange and tax rates; available liquidity and liquidity requirements, our ability to refinance our indebtedness, available cash and distributable reserves for, and other factors impacting, dividend payments and share repurchases, results of the share repurchase programs and other risks indicated in the risk factors included in ASML’s Annual Report on Form 20-F and other filings with and submissions to the US Securities and Exchange Commission. These forward-looking statements are made only as of the date of this document. We do not undertake to update or revise the forward-looking statements, whether as a result of new information, future events or otherwise.